RMTI
$3.18
Rockwell Medical IN
$.07
2.25%
RMTI
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  ($0.12)
Revenue:  $16.77 Mil
Thursday
Mar 12
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when RMTI reports earnings?
Beat
Meet
Miss

Where is RMTI's stock price going from here?
Up
Flat
Down
Stock chart of RMTI
Analysts
Summary of analysts' recommendations for RMTI
Score
Grade
Pivots
Resistance
$3.43
$3.34
$3.26

$3.17

Support
$3.09
$3.00
$2.92
Tweet
Growth
Description
Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able to duplicate kidney function in patients whose kidneys have failed to function properly.
Peers
BioMarin PharmaceuticalRegeneron PharmaceuticalsVertex PharmaceuticalsInterCeptZoetisJohnson & JohnsonMylanUltragenyx PharmaceuticalBristol-Myers SquibbAlkermes